IL18 and chronic obstructive pulmonary disease: After NAC treatment, the levels of IL-1β, IFN-γ, TNF-α, and IL-18 in COPD patients' serum were decreased, and IL-10 was increased conversely; no obvious change of TGF-β and IL-6 was observed (Figure 1(b)).